Vantage Investment Advisors’s Biogen BIIB Stock Holding History

Vantage Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$61K	Hold	172	–	–	0.01%	255
2018 Q2	$50K	Hold	172	–	–	0.01%	273
2018 Q1	$47K	Sell	172 -22	-11%	-$6.83K	0.01%	291
2017 Q4	$62K	Buy	194 +22	+13%	+$7.06K	0.01%	259
2017 Q3	$54K	Hold	172	–	–	0.01%	256
2017 Q2	$47K	Hold	172	–	–	0.01%	270
2017 Q1	$47K	Sell	172 -7	-4%	-$1.98K	0.02%	252
2016 Q4	$51K	Buy	179 +7	+4%	+$2.08K	0.02%	243
2016 Q3	$54K	Sell	172 -90	-34%	-$26.7K	0.02%	236
2016 Q2	$62K	Buy	262 +5	+2%	+$1.32K	0.03%	231
2016 Q1	$67K	Hold	257	–	–	0.03%	212
2015 Q4	$79K	Sell	257 -25	-9%	-$7.18K	0.04%	184
2015 Q3	$82K	Buy	282 +15	+6%	+$4.95K	0.05%	177
2015 Q2	$108K	Sell	267 -267	-50%	-$107K	0.06%	155
2015 Q1	$225K	Buy	534 +277	+108%	+$109K	0.06%	148
2014 Q4	$87K	Hold	257	–	–	0.05%	185
2014 Q3	$85K	Hold	257	–	–	0.05%	182
2014 Q2	$81K	Hold	257	–	–	0.05%	186
2014 Q1	$79K	Hold	257	–	–	0.05%	179
2013 Q4	$72K	Buy	+257	New	+$66.5K	0.05%	180

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vantage Investment Advisors's BIIB Position: Q3 2018 in Review

Vantage Investment Advisors held its Biogen (BIIB) position steady in Q3 2018 at 172 shares worth $61K. The position accounts for 0.01% of the portfolio, ranked #255.

Vantage Investment Advisors first reported a position in BIIB in Q4 2013 and has held it in 20 quarters since. The position peaked at $225K in Q1 2015. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Vantage Investment Advisors held 172 shares of Biogen worth $61K as of Q3 2018.
Vantage Investment Advisors left its Biogen share count unchanged in Q3 2018.
Biogen made up 0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #255 holding.
Vantage Investment Advisors first reported a position in Biogen in Q4 2013 and has held it in 20 quarters since.
Vantage Investment Advisors's Biogen position peaked at $225K in Q1 2015.
1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.